Arrowhead Pharmaceuticals (ARWR) total assets

Total assets · fiscal 2026
$1.74B

Arrowhead Pharmaceuticals (ARWR) had total assets of $1.74B at the end of fiscal 2026 (September 30, 2026). That is 25.5% higher than the $1.39B of fiscal 2025. Figures as of 18 Nov 2026, 05:25 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2026
$1.74B
Change on fiscal 2025
+25.5%
Growth, 5 years
+19.6% a year
Growth, 10 years
+29.8% a year
Highest on record
$1.74Bfiscal 2026
Lowest on record
$12.35Mfiscal 2010
Fiscal years on record
172010–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Arrowhead Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2026 total assets grew at a compound 19.6% a year; over ten years the rate was 29.8% a year. Across the 17 fiscal years on record (2010–2026), the highest was $1.74B in fiscal 2026 and the lowest $12.35M in fiscal 2010.

History · 17 fiscal years

Total assets by fiscal year

Arrowhead Pharmaceuticals total assets, year by year

Arrowhead Pharmaceuticals (ARWR) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2026$1.74B 25.5% up
2025$1.39B 21.5% up
2024$1.14B 48.9% up
2023$765.55M 10.6% up
2022$691.94M 2.6% down
2021$710.15M 35.9% up
2020$522.50M 49.4% up
2019$349.85M 213.5% up
2018$111.61M 7.3% up
2017$104.02M 18.8% down
2016$128.18M 3.1% down
2015$132.27M 27.7% down
2014$182.82M 389.7% up
2013$37.33M 125.9% up
2012$16.53M 4.0% up
2011$15.89M 28.6% up
2010$12.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Arrowhead Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Axsome Therapeutics AXSM$689.81M2025
Chemed CHE$1.54B2025
Oruka Therapeutics ORKA$488.62M2025
Arrowhead Pharmaceuticals ARWR$1.74B2026
MSA Safety MSA$2.55B2025
CG Oncology CGON$791.59M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ARWR

Arrowhead Pharmaceuticals, figure by figure

Arrowhead Pharmaceuticals (ARWR) overview: price, valuation and scorecardAll health care companies by market value

Arrowhead Pharmaceuticals total assets: questions and answers

How large are Arrowhead Pharmaceuticals's total assets?

Arrowhead Pharmaceuticals (ARWR) had total assets of $1.74B at the end of fiscal 2026 (September 30, 2026). That is 25.5% higher than the $1.39B of fiscal 2025.

What is the growth rate of Arrowhead Pharmaceuticals's total assets?

Over the five fiscal years to 2026 total assets grew at a compound 19.6% a year; over ten years the rate was 29.8% a year.

What are the highest and lowest total assets figures on record for Arrowhead Pharmaceuticals?

Across the 17 fiscal years on record (2010–2026), the highest was $1.74B in fiscal 2026 and the lowest $12.35M in fiscal 2010.

How is Arrowhead Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Arrowhead Pharmaceuticals (ARWR) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/ARWR/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.